Health Care & Life Sciences » Pharmaceuticals | Clearside Biomedical Inc.

Clearside Biomedical Inc. | Ownership

Companies that own Clearside Biomedical Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Wellington Management Co. LLP
4,365,091
13.63%
-91,743
0.01%
06/30/2018
BlackRock Fund Advisors
1,720,945
5.37%
595,924
0%
06/30/2018
RA Capital Management LLC
1,525,000
4.76%
0
0.56%
06/30/2018
Millennium Management LLC
1,246,044
3.89%
-151,688
0.01%
06/30/2018
Cormorant Asset Management LP
1,200,000
3.75%
-680,880
0.57%
06/30/2018
The Vanguard Group, Inc.
1,173,198
3.66%
56,569
0%
06/30/2018
Sphera Funds Management Ltd.
1,068,720
3.34%
38,720
1.05%
06/30/2018
Rock Springs Capital Management LP
975,000
3.05%
0
0.24%
06/30/2018
NorthPointe Capital LLC
816,140
2.54%
816,140
0.73%
06/30/2018
Perceptive Advisors LLC
707,581
2.21%
-7,600
0.11%
06/30/2018

About Clearside Biomedical

View Profile
Address
900 North Point parkway
Alpharetta Georgia 30005
United States
Employees -
Website http://www.clearsidebio.com
Updated 07/08/2019
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.